ArticleActa pharmacologica Sinica2018

SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models.

Xi-Fei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.